scholarly journals Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial

2018 ◽  
Vol 18 (2) ◽  
pp. 155-161 ◽  
Author(s):  
Somphou Sayasone ◽  
Jennifer Keiser ◽  
Isabel Meister ◽  
Youthanavanh Vonghachack ◽  
Syda Xayavong ◽  
...  
Keyword(s):  
Opisthorchis Viverrini ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 2 Trial

scholarly journals Efficacy and safety of mefloquine, artesunate, mefloquine–artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial

2011 ◽  
Vol 11 (2) ◽  
pp. 110-118 ◽  
Author(s):  
Phonepasong Soukhathammavong ◽  
Peter Odermatt ◽  
Somphou Sayasone ◽  
Youthanavanh Vonghachack ◽  
Penelope Vounatsou ◽  
...  
Keyword(s):  
Opisthorchis Viverrini ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase

Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial

2019 ◽  
Vol 7 (3) ◽  
pp. 189-199 ◽  
Author(s):  
Michael P Whyte ◽  
Thomas O Carpenter ◽  
Gary S Gottesman ◽  
Meng Mao ◽  
Alison Skrinar ◽  
...  
Keyword(s):  
Phase 2 ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase

scholarly journals PO58 EFFICACY AND SAFETY OF FIRST-LINE EVEROLIMUS PLUS LETROZOLE IN ER+ HER2− METASTATIC BREAST CANCER: A MULTI-CENTER, OPEN-LABEL, PHASE 2 TRIAL BOLERO-4

The Breast ◽  
2013 ◽  
Vol 22 ◽  
pp. S39-S40
Author(s):  
Sergio Azevedo ◽  
Thomas Bachelo ◽  
William Gradishar ◽  
Francois Ringeisen ◽  
Thomas Brechenmacher ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
First Line ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document